GPN Vaccines
Creating a comprehensive vaccine targeting Streptococcus pneumoniae, the leading bacterial pathogen worldwide.
Launch date
Employees
Market cap
-
Enterprise valuation
€176m (Public information from Jun 2024)
Company register number 621789008
Adelaide South Australia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Grant | ||
| N/A | AUD1.1m | Seed | |
AUD300k | Grant | ||
$1.0m | Grant | ||
* | AUD7.0m | Series A | |
AUD1.0m | Grant | ||
* | N/A | Series A | |
* | AUD9.0m | Series A | |
* | AUD18.0m Valuation: AUD300m | Series B | |
| Total Funding | €22.3m | ||